Q3 EPS Estimate for Alignment Healthcare Reduced by Analyst

Key Points

• Analysts at Leerink Partners have revised their Q3 2025 earnings per share (EPS) estimate for Alignment Healthcare down to ($0.08), reflecting a decline from the previous estimate of ($0.07).
• Alignment Healthcare reported a revenue of $1.02 billion for the last quarter, surpassing the projected $960.25 million, while its earnings per share was $0.07, beating consensus estimates.
• Alignment Healthcare's stock has recently experienced a decline of 5.9%, with a market cap of $2.57 billion and an average target price of $17.61 from analysts.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) - Research analysts at Leerink Partnrs dropped their Q3 2025 earnings per share estimates for shares of Alignment Healthcare in a research report issued on Wednesday, July 30th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings per share of ($0.08) for the quarter, down from their prior estimate of ($0.07). The consensus estimate for Alignment Healthcare's current full-year earnings is ($0.69) per share. Leerink Partnrs also issued estimates for Alignment Healthcare's Q4 2025 earnings at ($0.15) EPS, FY2025 earnings at ($0.20) EPS, Q1 2026 earnings at $0.03 EPS, Q2 2026 earnings at $0.20 EPS, Q3 2026 earnings at ($0.01) EPS, Q4 2026 earnings at ($0.09) EPS, FY2028 earnings at $0.78 EPS and FY2029 earnings at $1.28 EPS.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. The business had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $960.25 million. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The company's quarterly revenue was up 49.0% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.13) earnings per share.

A number of other research firms have also issued reports on ALHC. Robert W. Baird upped their price target on Alignment Healthcare from $17.00 to $22.00 and gave the company an "outperform" rating in a research report on Tuesday, April 15th. UBS Group raised their target price on Alignment Healthcare from $16.00 to $17.00 and gave the stock a "neutral" rating in a research note on Friday, May 2nd. Barclays raised shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and boosted their price target for the company from $9.00 to $13.00 in a research report on Thursday. Wall Street Zen raised shares of Alignment Healthcare from a "hold" rating to a "buy" rating in a report on Saturday. Finally, Stifel Nicolaus lifted their target price on shares of Alignment Healthcare from $18.00 to $23.00 and gave the stock a "buy" rating in a research note on Tuesday, April 8th. Four equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $17.61.

Alignment Healthcare Stock Down 5.9%

ALHC stock opened at $12.97 on Monday. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. The firm has a 50-day moving average of $13.89 and a two-hundred day moving average of $15.34. Alignment Healthcare has a 12 month low of $7.92 and a 12 month high of $21.06. The company has a market cap of $2.57 billion, a price-to-earnings ratio of -46.32 and a beta of 1.16.

Institutional Investors Weigh In On Alignment Healthcare

Several institutional investors and hedge funds have recently modified their holdings of ALHC. Sei Investments Co. acquired a new stake in shares of Alignment Healthcare during the fourth quarter worth about $944,000. KLP Kapitalforvaltning AS acquired a new stake in Alignment Healthcare during the 4th quarter worth approximately $194,000. Vanguard Group Inc. lifted its holdings in Alignment Healthcare by 1.7% during the 4th quarter. Vanguard Group Inc. now owns 9,818,071 shares of the company's stock worth $110,453,000 after buying an additional 166,837 shares in the last quarter. Norges Bank purchased a new position in Alignment Healthcare in the 4th quarter valued at approximately $3,386,000. Finally, Arrowstreet Capital Limited Partnership grew its stake in shares of Alignment Healthcare by 133.5% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 147,478 shares of the company's stock worth $1,659,000 after acquiring an additional 84,315 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company's stock.

Insider Transactions at Alignment Healthcare

In other Alignment Healthcare news, insider Christopher J. Joyce sold 15,491 shares of the stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $16.01, for a total transaction of $248,010.91. Following the completion of the transaction, the insider owned 374,531 shares of the company's stock, valued at $5,996,241.31. This trade represents a 3.97% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, President Dawn Christine Maroney sold 30,000 shares of the business's stock in a transaction that occurred on Monday, July 14th. The shares were sold at an average price of $13.44, for a total transaction of $403,200.00. Following the completion of the sale, the president directly owned 2,042,899 shares in the company, valued at $27,456,562.56. This trade represents a 1.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 17,700,753 shares of company stock worth $269,911,757 in the last 90 days. Insiders own 6.60% of the company's stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.